When I Was 17, It Was a Very Good Year...

How market analyst Sean McCloskey went from a low-class nothing to a Wall Street something. How market analyst Sean McCloskey went from a low-class nothing to a Wall Street something. [Energy and Capital logo] When I Was 17, It Was a Very Good Year… [Sean McCloskey Photo] By [Sean McCloskey]( Written Mar 04, 2022 When I was 17, I cashed out my first stock investment for a 420% gain, netting me roughly $9,000 in profits. This was all on top of being in the top 10% of my graduating class and lettering multiple times as a top multi-sport varsity athlete. Simply put, when I was 17, it was a very good year. It was also the peak of the tech boom... Which is how I cashed out my first 420% gain in the markets and started on my path from becoming a small-town nothing to a big Wall Street something. Let Me Tell You About Bubba I didn’t know my great-grandmother, Bubba. She passed away when I was just an infant. But my father’s grandmother had a profound impact on my life and still does to this day. In her will, she left me 18 shares of IBM Corp. (NYSE: IBM). I had a stake in the market before I could talk. Obviously, as a baby and then a toddler, I knew nothing about stocks, so my position just sat there. My parents deposited the dividend checks I received into a savings account. But by elementary school, even though I still knew nothing about the markets, I would take my local newspaper, the Times-Herald Record, and pore over the print. I would look at tickers, prices, and volume, trying to piece it all together. Strange Substance Minting Millionaires? This little-known substance is about to change the world... It’s the thinnest material in the known universe... it’s up to 300x stronger than steel... and it’s harder than diamond. Until recently a single pound of [this material]( cost $43,500. That’s almost twice as expensive as gold. But one tiny company has developed a [patented process]( to make this substance out of nothing but natural gas. Shares still trade for less than $3. However, there’s not much time to act... Because once this makes the headlines, the stock could skyrocket in record time. [Get the full story on this unique opportunity now.]( Through the 1980s, my shares did nothing. By the early '90s, I was even down in my position. But I was content. The dividend checks I received four times a year kept me in the best comic books and baseball cards a kid could ask for. I was happy. By the time I reached high school in 1996, everything changed. The tech boom was kicking off and over the next few years, my 18 shares jumped fivefold from roughly $25 to about $130. Even better, my stake had quadrupled to 72 shares after two stock splits in 1997 and 1999. By the time I was filling out college applications, my position in IBM had grown from $450 to $9,000! Let me tell you, when you’re young and planning for college, $9,000 goes a long way. That money helped me pay for books and living expenses my first two years away! The experience also taught me a valuable lesson about investing that still plays an important role in my approach to the markets to this day. You don’t need to be rich to reap the rewards the stock market has to offer. Even with just one open position in the market, I was able to add to the quality of my life for nearly 20 years! Sure, my goals were small. But I achieved them, and regular Main Street investors just like me can significantly change their lives for the better with the right investments too. Realizing this lesson at a very early and impressionable age is part of the reason why I’m writing to you today. You see, I’ve studied the markets for nearly 35 years now, and it’s made me a highly successful investor and trader. Over the years, I’ve covered multiple sectors on the hunt for moneymaking opportunities. This has taken me on a journey into the inner circles of industries from energy and tech to cryptocurrencies and cannabis. The #1 Strategy for Biotech Stocks? It’s no secret that biotech is the most exciting investment arena there is. There’s never a shortage of demand for new treatments for the world’s worst diseases, like cancer, Alzheimer’s, and arthritis. And with my new trading system, “Project Greenlight,” you’ll always know with up to 95% confidence which of those new medicines will be approved by the FDA and which won’t... This could set investors up to make six figures or more in biotech profits. And right now, there's a tiny biotech firm trading for pennies on the dollar with a medicine that’s on the brink of FDA approval... [Learn more about this unique opportunity today.]( Of course, I’m not pretending I win on every trade or investment, but since 2018, when one of the biggest financial publishers in the world hired me as a young analyst, I’ve won on more than 300 of the roughly 400 investments I’ve recommended, including: - 391% with Inspire Medical Systems Inc. (NYSE: INSP) - 340% with Innovative Industrial Properties (NYSE: IIPR) - 334% with Livongo Health Inc. (NASDAQ: LVGO) - 225% with Seagen Inc. (NASDAQ: SGEN) - 126% with Green Thumb Industries (OTC: GTBIF) Most recently, however, I’ve been working on a secret project. In short, it’s a new trading strategy that could supercharge the types of investments I’ve been able to pinpoint previously and juice them into short-term trades that could produce gains 49 times higher than any long-term investment you might make. In fact, I’ve secretly tested this strategy in Energy and Capital over the past nine months, and the results have been staggering. Across all the trades we made in 2021, we’ve averaged a return of 130% (even including the few we lost on). This was all in a time frame of about four weeks per trade. These included: - 128% on TSM in 28 days... - 186% on TSM again in 12 days... - 295% on SBUX in seven days... - 205% on CVX in 20 days... - 207% on CVX again in 22 days... - 597% on AMD in 16 days... - And 1,121% again on AMD in just 12 days! A $1,000 investment into each of those opportunities would’ve grown to $34,390! This isn’t hyperbole, either. These are real trades my followers and I cashed in on in 2021 for real returns. So while most Wall Street experts are predicting a down year for stocks in 2022, I want to give you the opportunity to fly in the face of common wisdom and potentially earn triple-digit returns on every trade you make this year. Breaking News: 6 New Cryptos Set to Be Bigger Than Bitcoin It’s no secret that cryptocurrencies are at the absolute cutting edge of investing. In fact, CBS News recently reported that Bitcoin alone created over 100,000 new millionaires... And CNBC put forth a headline that reads “I Just Became a Dogecoin Millionaire.” But what the media aren't covering... is what’s coming next. They don’t want you to know about the six new coins expected to be FAR BIGGER than any previous crypto gain...[The details are inside this new report.]( Your Personal Invitation to Join My Asymmetric Profits VIP Access List Today I want to introduce you to what may be the most important event ever in the history of Angel Publishing: your immediate VIP access to my brand-new Asymmetric Profits event I’m hosting on THURSDAY, March 10, 2022, at 4:00 p.m. EST (1 p.m. PST). [Here’s Your Personal Invitation to Join the Asymmetric Profits VIP Access List]( Imagine making one simple trade and locking in up to 49x bigger returns than you could trading the stock — all in as little as one week. Well, that’s exactly the opportunity I’m offering today, and this is how you can be part of this first-of-its-kind event. By signing up for the special event right now, you’ll get immediate VIP access to my brand-new Asymmetric Profits event on THURSDAY, March 10, 2022, at 4:00 p.m. EST (1 p.m. PST). VIP access means you’ll have the chance to be first in line to see this powerful new strategy in action — a full day before any of my other readers! This is a limited event, so only a handful of spots are available. But your VIP access not only guarantees you a seat — it also gives you an incredible advantage over everyone else (you’ll see exactly how during the event). It all starts when you accept my invitation today.... [Here’s Your Personal Invitation to Join the Asymmetric Profits VIP Access List]( When you get to that page, all you have to do is leave your best email address — that’s it. You’ll be a VIP! [Sign up here now to claim your VIP access.]( To your wealth, Sean McCloskey Editor, Energy and Capital [[follow basic]@TheRL_McCloskey on Twitter]( After spending 10 years in the consumer tech reporting and educational publishing industries, Sean has since redevoted himself to one of his original passions: identifying and cashing in on the most lucrative opportunities the market has to offer. As the former managing editor of multiple investment newsletters, he's covered virtually every sector of the market, ranging from energy and tech to gold and cannabis. Over the years, Sean has offered his followers the chance to score numerous triple-digit gains, and today he continues his mission to deliver followers the best chance to score big wins on Wall Street and beyond as an editor for Energy and Capital. Browse Our Archives [How Renewable Energy Protects Our Energy Infrastructure]( [(Updated) Oil Outlook 2022: My #1 Oil Stock for $100 Crude]( [How to Make a Fortune From Olive Presses]( [Vlad vs. the World]( [Putin Chooses War, and the Extreme Energy Crisis That Comes With It]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here]( and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2022, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.]( ---------------------------------------------------------------